Assembly Biosciences, Inc. (ASMB)
Assembly Biosciences Market Cap: 444.30M for Jan. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Gilead Sciences, Inc. | 155.43B |
| CorMedix, Inc. | 539.70M |
| Supernus Pharmaceuticals, Inc. | 2.854B |
| NovaBay Pharmaceuticals, Inc. | 868.21M |
| Palatin Technologies, Inc. | 16.00M |
Market Cap Related Metrics
| PS Ratio | 6.501 |
| Price to Book Value | 2.432 |
| Price | 28.09 |
| Earnings Yield | -17.10% |